9811 Results
4

WVXU: One year on: Why do people with COVID-19 lose smell and taste?

March 8, 2021

Ahmad Sedaghat, MD, PhD, associate professor in the University of Cincinnati Department of Otolaryngology-Head and Neck Surgery, spoke with WVXU about COVID-19's impact on the sense of taste and smell. His discussion comes as the one-year anniversary of large scale quarantine orders being issues across the nation in the wake of the pandemic.

5

ENT Today: Preparing yourself and your practice for a surge of COVID patients

December 16, 2020

Ahmad R. Sedaghat, MD, PhD, director of the division of rhinology, allergy, and anterior skull base surgery at the University of Cincinnati College of Medicine, told ENT Today that because COVID-19 is a viral infection, patients may experience more severe body aches, lethargy, and fatigue compared to a bacterial sinus infection.

6

USA Today: Up the nose, into the brain?

July 20, 2020

Ahmad Sedaghat, MD, PhD, associate professor in the UC College of Medicine and UC Health physician, spoke with journalist Terry DeMio about a correlation between the loss of smell and taste and depression in COVID-19 patients.

7

Ivanhoe Broadcast: Migraine sufferers—beware of fall

October 19, 2020

Vincent Martin, MD, professor and director of the Headache and Facial Pain Center at the University of Cincinnati, says research indicates weather changes are a primary cause of migraine. He spoke with Ivanhoe Broadcast for a segment about the arrival of fall and unfortunately migraine for some.

8

Combating ‘chemobrain’ with music

August 17, 2020

UC researchers from the College of Medicine and DAAP are working together to see how a music app may help patients who experience "chemobrain."

9

Breaching the blood-brain barrier to treat tumors

May 7, 2021

Researchers at the University of Cincinnati, in collaboration with the Georgia Institute of Technology and Emory University, have found that using ultrasound combined with RNA-loaded nanoparticles could help infiltrate the blood-brain barrier and deliver targeted, more effective treatment to brain tumors, while eliminating uncomfortable side effects.